@sarge17 unless it is a formal requirement of the asx it is a fiasco.
As l said previously there is no information that will be contained in this half yearly that isn't already in the public domain through the 2 previous quarterly reports.
The half yearly report is supposed to deal with all things up to 31 December and not beyond
Ann: VivaGel BV US FDA Appeal Outcome, page-55
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.002(2.04%) |
Mkt cap ! $41.81M | |||
| Open | High | Low | Value | Volume |
| 9.8¢ | 10.0¢ | 9.7¢ | $37.90K | 384.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 68758 | 9.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 213426 | 6 |
View Market Depth
| Last trade - 16.10pm 05/11/2024 (20 minute delay) ? |
| SPL (ASX) Chart |